MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

03 Nov 2023 Evaluate
The Total revenue for the quarter ended September 2023 of  Rs. 3049.30 millions remain, more or less, the same.Net profit showed a marginal rise at Rs. 655.70 millions for the quarter ended September 2023, as compared to corresponding quarter of last year.OP of the company witnessed a marginal growth to 947.10 millions from 942.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202306 202206 % Var
Sales 3049.30 2975.50 2.48 3049.30 2975.50 2.48 12296.20 11144.10 10.34
Other Income 60.50 34.20 76.90 60.50 34.20 76.90 183.90 131.90 39.42
PBIDT 947.10 942.40 0.50 947.10 942.40 0.50 3430.70 2808.70 22.15
Interest 1.80 1.60 12.50 1.80 1.60 12.50 7.70 4.20 83.33
PBDT 945.30 940.80 0.48 945.30 940.80 0.48 3423.00 2804.50 22.05
Depreciation 64.80 74.80 -13.37 64.80 74.80 -13.37 281.00 270.80 3.77
PBT 880.50 866.00 1.67 880.50 866.00 1.67 3142.00 2533.70 24.01
TAX 224.80 229.40 -2.01 224.80 229.40 -2.01 847.30 608.50 39.24
Deferred Tax 1.90 10.30 -81.55 1.90 10.30 -81.55 -50.60 0.40 -12750.00
PAT 655.70 636.60 3.00 655.70 636.60 3.00 2294.70 1925.20 19.19
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 31.06 31.67 -1.93 31.06 31.67 -1.93 27.90 25.20 10.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..